Kisunla for Alzheimer’s: A Trial Participant’s Inside Story
By
Lauren Fetten
| July 24th, 2024
In the past year, the FDA approved two landmark new Alzheimer’s drugs: monoclonal antibodies designed to attack the disease’s underlying pathology, as opposed to…